{"id":341324,"date":"2025-08-20T14:37:21","date_gmt":"2025-08-20T14:37:21","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-sarepta-therapeutics\/"},"modified":"2025-08-20T14:37:21","modified_gmt":"2025-08-20T14:37:21","slug":"how-to-buy-sarepta-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/","title":{"rendered":"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-341324","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131"},"description":"Sarepta Therapeutics (SRPT) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin, g\u00fcncel fiyat $20.18, riskler, f\u0131rsatlar ve 2025 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci hakk\u0131nda uzman analizi ile.","description_source":{"label":"Description","type":"textarea","formatted_value":"Sarepta Therapeutics (SRPT) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin, g\u00fcncel fiyat $20.18, riskler, f\u0131rsatlar ve 2025 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci hakk\u0131nda uzman analizi ile."},"intro":"Keskin genetik t\u0131pta yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Sarepta Therapeutics (SRPT), biyoteknoloji inovasyonunun heyecan verici s\u0131n\u0131r\u0131n\u0131 temsil ediyor\u2014ama ayn\u0131 zamanda y\u00fcrek hoplatan risklerini de. Bu \u015firket, devrim niteli\u011findeki bilim ve d\u00fczenleyici zorluklar\u0131n kesi\u015fim noktas\u0131nda duruyor ve 2025'in en \u00e7ok konu\u015fulan hisselerinden biri haline geliyor. G\u00fcncel fiyat hareketlerinden bu biyoteknoloji riskinin b\u00fcy\u00fck kazan\u00e7 sa\u011flay\u0131p sa\u011flamayaca\u011f\u0131na kadar her \u015feyi detayland\u0131raca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"Keskin genetik t\u0131pta yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Sarepta Therapeutics (SRPT), biyoteknoloji inovasyonunun heyecan verici s\u0131n\u0131r\u0131n\u0131 temsil ediyor\u2014ama ayn\u0131 zamanda y\u00fcrek hoplatan risklerini de. Bu \u015firket, devrim niteli\u011findeki bilim ve d\u00fczenleyici zorluklar\u0131n kesi\u015fim noktas\u0131nda duruyor ve 2025'in en \u00e7ok konu\u015fulan hisselerinden biri haline geliyor. G\u00fcncel fiyat hareketlerinden bu biyoteknoloji riskinin b\u00fcy\u00fck kazan\u00e7 sa\u011flay\u0131p sa\u011flamayaca\u011f\u0131na kadar her \u015feyi detayland\u0131raca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 SRPT Hisse Senedi: G\u00fcncel Durum ve Kritik Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla, Sarepta Therapeutics (SRPT) <strong>$20.18<\/strong> fiyat\u0131ndan i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat hem umut hem de tehlike dolu dramatik bir hikaye anlat\u0131yor. Takviminize i\u015faretleyin: <strong>Kas\u0131m 2025<\/strong> kesinlikle kritik. Sarepta'n\u0131n bir sonraki kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih bu ve son geli\u015fmeler g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, bu piyasa hareketlili\u011fi yaratabilecek bir an olabilir.<\/p> <h3>G\u00fcvenlik Haberleri SRPT Hissesini Nas\u0131l Hareket Ettiriyor<\/h3> <p>Son alt\u0131 ay, d\u00fczenleyici haberlerin ana s\u00fcr\u00fcc\u00fc oldu\u011fu bir h\u0131z treni oldu:<\/p> <ul> <li><strong>18 Mart 2025<\/strong>: \u0130lk hasta \u00f6l\u00fcm\u00fc a\u00e7\u0131klamas\u0131 \u2192 Hisse tek g\u00fcnde <strong>%27<\/strong> d\u00fc\u015ft\u00fc<\/li> <li><strong>24 Haziran 2025<\/strong>: FDA soru\u015fturma duyurusu \u2192 Ek <strong>%15 d\u00fc\u015f\u00fc\u015f<\/strong><\/li> <li><strong>17 Temmuz 2025<\/strong>: \u00dc\u00e7\u00fcnc\u00fc hasta \u00f6l\u00fcm\u00fc ortaya \u00e7\u0131kt\u0131 \u2192 Ertesi g\u00fcn <strong>%40 \u00e7\u00f6k\u00fc\u015f<\/strong><\/li> <li><strong>28 Temmuz 2025<\/strong>: FDA ambulatuvar hastalar i\u00e7in yeniden ba\u015flatmay\u0131 onaylad\u0131 \u2192 <strong>%23 toparlanma s\u0131\u00e7ramas\u0131<\/strong><\/li> <\/ul> <p>Desen a\u00e7\u0131k: olumsuz g\u00fcvenlik haberleri an\u0131nda ciddi d\u00fc\u015f\u00fc\u015flere neden olurken, olumlu d\u00fczenleyici geli\u015fmeler keskin toparlanmalar\u0131 tetikliyor. Bu volatilite SRPT ile zamanlamay\u0131 her \u015fey yap\u0131yor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu: Umuttan Krize<\/h2> <p>SRPT'nin \u015eubat'tan A\u011fustos 2025'e yolculu\u011fu bir t\u0131bbi gerilim roman\u0131 gibi:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: Yakla\u015f\u0131k $85 civar\u0131nda i\u015flem g\u00f6r\u00fcyordu (kriz \u00f6ncesi g\u00fcven)<\/li> <li><strong>Mart 2025<\/strong>: \u0130lk g\u00fcvenlik a\u00e7\u0131klamas\u0131ndan sonra $45'e d\u00fc\u015ft\u00fc<\/li> <li><strong>Haziran 2025<\/strong>: Geni\u015fletilmi\u015f FDA soru\u015fturmas\u0131yla $32'ye geriledi<\/li> <li><strong>Temmuz 2025<\/strong>: \u00dc\u00e7\u00fcnc\u00fc hasta \u00f6l\u00fcm\u00fc sonras\u0131 $19'a \u00e7ak\u0131ld\u0131<\/li> <li><strong>A\u011fustos 2025<\/strong>: K\u0131smi FDA onay\u0131 ile $20.18'e toparland\u0131<\/li> <\/ul> <p>Bu, zirveden dip seviyeye <strong>%76'l\u0131k bir d\u00fc\u015f\u00fc\u015f<\/strong> anlam\u0131na geliyor\u2014her yat\u0131r\u0131mc\u0131n\u0131n sinirlerini s\u0131nayacak kadar. $19'dan gelen son s\u0131\u00e7rama biraz f\u0131rsat avc\u0131l\u0131\u011f\u0131na i\u015faret ediyor, ancak teknik zararlar ciddi kalmaya devam ediyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 (Y\u0131l Sonu)<\/strong>: $25-35 \u2192 <strong>TUT<\/strong> (Kas\u0131m kazan\u00e7 a\u00e7\u0131klamas\u0131n\u0131 bekleyin)<\/li> <li><strong>2026<\/strong>: $40-60 (d\u00fczenleyici \u00e7\u00f6z\u00fcm ve sat\u0131\u015f toparlanmas\u0131 varsay\u0131larak)<\/li> <li><strong>2028<\/strong>: $80-120 (gen terapisi platformu uzun vadede g\u00fcvenli olursa)<\/li> <li><strong>2030<\/strong>: $100-150+ (g\u00fcvenlik endi\u015feleri \u00e7\u00f6z\u00fcl\u00fcrse potansiyel blockbuster stat\u00fcs\u00fc)<\/li> <\/ul> <p>Analistlerin ortalama hedefi $45.65 olup <strong>%126 y\u00fckseli\u015f potansiyeli<\/strong> g\u00f6steriyor, ancak hedefler $7 ile $170 aras\u0131nda de\u011fi\u015fiyor, yani kimse tam olarak bilmiyor. Bu, biyoteknoloji spek\u00fclasyonunun en saf hali.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Yat\u0131r\u0131mc\u0131lar\u0131 Uykusuz B\u0131rakan Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici iptal<\/strong>: FDA ELEVIDYS onay\u0131n\u0131 tamamen geri \u00e7ekebilir<\/li> <li><strong>Dava tsunamisi<\/strong>: Birden fazla toplu dava milyarlarca dolara mal olabilir (<a href=\"https:\/\/www.rgrdlaw.com\/cases-sarepta-therapeutics-inc-class-action-lawsuit-srpt.html\">Robbins Geller<\/a>)<\/li> <li><strong>\u0130flas riski<\/strong>: $414M negatif nakit ak\u0131\u015f\u0131 sonsuza kadar devam edemez<\/li> <li><strong>\u0130tibar kayb\u0131<\/strong>: Gen terapisi platformuna olan g\u00fcven sars\u0131ld\u0131<\/li> <\/ul> <h3>Cesur Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>FDA k\u0131smi onay\u0131<\/strong>: Ambulatory hastalar tedaviye geri d\u00f6nd\u00fc (<a href=\"https:\/\/www.statnews.com\/2025\/07\/28\/sarepta-duchenne-elevidys-hold-ambulatory\/\">STAT News<\/a>)<\/li> <li><strong>Pazar liderli\u011fi<\/strong>: Hala Duchenne kas distrofisi tedavisinde lider<\/li> <li><strong>De\u011ferinin alt\u0131nda potansiyel<\/strong>: DCF analizine g\u00f6re %32 i\u00e7sel de\u011ferin alt\u0131nda<\/li> <li><strong>Short squeeze potansiyeli<\/strong>: Yo\u011fun k\u0131sa pozisyonlar h\u0131zl\u0131 toparlanmay\u0131 tetikleyebilir<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Kas\u0131m kazan\u00e7lar\u0131n\u0131 bekleyin<\/strong>: \u015eu anda \u00e7ok fazla belirsizlik var<\/li> <li><strong>Al\u0131m yapacaksan\u0131z k\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3'\u00fcnden fazlas\u0131n\u0131 ay\u0131rmay\u0131n<\/li> <li><strong>S\u0131k\u0131 stop-loss koyun<\/strong>: Bu hisse bir gecede %40 d\u00fc\u015febilir<\/li> <li><strong>Riski \u00e7e\u015fitlendirin<\/strong>: Stabil sa\u011fl\u0131k hisseleri ile dengeleyin<\/li> <\/ol> <p>Mizahi bir yorum: \"SRPT ticareti, anestezisiz kalp ameliyat\u0131 yapmak gibidir\u2014hayatta kal\u0131rsan\u0131z heyecan verici, ama hasta masada \u00f6lebilir.\"<\/p> <h2>\u2705 Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ticaret platformu se\u00e7in<\/td><td>ABD biyoteknoloji hisseleri i\u00e7in NASDAQ eri\u015fimi sunmal\u0131<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Y\u00fcksek volatilite nedeniyle k\u00fc\u00e7\u00fck miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"SRPT\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Sadece limit emirleri\u2014bu volatilitede piyasa emirleri asla<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon oranlar\u0131n\u0131n %0.5'in alt\u0131nda oldu\u011fundan emin olun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Neden Volatil Biyoteknoloji Ticareti \u0130\u00e7in Uygun<\/h2> <p>SRPT gibi hisselerin ticareti, Pocket Option'\u0131n m\u00fckemmel sundu\u011fu esneklik gerektirir:<\/p> <ul> <li><strong>$5 minimum depozito<\/strong> \u2014 ger\u00e7ek para ile stratejileri test edin, kira paran\u0131z\u0131 riske atmay\u0131n<\/li> <li><strong>An\u0131nda do\u011frulama<\/strong> \u2014 herhangi bir kimlik y\u00fckleyin ve dakikalar i\u00e7inde ticarete ba\u015flay\u0131n, g\u00fcnler de\u011fil<\/li> <li><strong>Kripto dostu \u00e7ekimler<\/strong> \u2014 f\u0131rsatlar do\u011fdu\u011funda kazanc\u0131n\u0131z\u0131 h\u0131zl\u0131ca \u00e7ekin<\/li> <\/ul> <p>G\u00fcnde %40 hareket edebilen biyoteknoloji hisseleri i\u00e7in, geleneksel brokerlerin sunamad\u0131\u011f\u0131 platform \u00e7evikli\u011fi gerekir.<\/p> <h2>\ud83c\udf0d Sarepta 2025'te: Kriz ve F\u0131rsat<\/h2> <p>Sarepta Therapeutics, \u00fc\u00e7 FDA onayl\u0131 tedavi ile Duchenne kas distrofisi tedavi pazar\u0131nda lider konumda, ancak 2025 neredeyse \u00f6l\u00fcm deneyimi olarak hat\u0131rlanacak. \u015eirket, son aksiliklere ra\u011fmen hassas genetik t\u0131pta liderli\u011fini s\u00fcrd\u00fcr\u00fcyor, piyasa de\u011feri $1.97 milyar ve y\u0131ll\u0131k geliri $2.48 milyar (<a href=\"https:\/\/stockanalysis.com\/stocks\/srpt\/\">StockAnalysis<\/a>).<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: Temmuz 2025'te Sarepta, 2026'ya kadar $400M tasarruf etmek i\u00e7in 500 \u00e7al\u0131\u015fan\u0131n\u0131 (i\u015f g\u00fcc\u00fcn\u00fcn %36's\u0131) i\u015ften \u00e7\u0131karaca\u011f\u0131n\u0131 duyurdu\u2014g\u00fcvenlik sorunlar\u0131n\u0131n ard\u0131ndan en b\u00fcy\u00fck biyoteknoloji yeniden yap\u0131lanmalar\u0131ndan biri (<a href=\"https:\/\/en.wikipedia.org\/wiki\/Sarepta_Therapeutics\">Wikipedia<\/a>).<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 SRPT Hisse Senedi: G\u00fcncel Durum ve Kritik Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla, Sarepta Therapeutics (SRPT) <strong>$20.18<\/strong> fiyat\u0131ndan i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat hem umut hem de tehlike dolu dramatik bir hikaye anlat\u0131yor. Takviminize i\u015faretleyin: <strong>Kas\u0131m 2025<\/strong> kesinlikle kritik. Sarepta&#8217;n\u0131n bir sonraki kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih bu ve son geli\u015fmeler g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, bu piyasa hareketlili\u011fi yaratabilecek bir an olabilir.<\/p>\n<h3>G\u00fcvenlik Haberleri SRPT Hissesini Nas\u0131l Hareket Ettiriyor<\/h3>\n<p>Son alt\u0131 ay, d\u00fczenleyici haberlerin ana s\u00fcr\u00fcc\u00fc oldu\u011fu bir h\u0131z treni oldu:<\/p>\n<ul>\n<li><strong>18 Mart 2025<\/strong>: \u0130lk hasta \u00f6l\u00fcm\u00fc a\u00e7\u0131klamas\u0131 \u2192 Hisse tek g\u00fcnde <strong>%27<\/strong> d\u00fc\u015ft\u00fc<\/li>\n<li><strong>24 Haziran 2025<\/strong>: FDA soru\u015fturma duyurusu \u2192 Ek <strong>%15 d\u00fc\u015f\u00fc\u015f<\/strong><\/li>\n<li><strong>17 Temmuz 2025<\/strong>: \u00dc\u00e7\u00fcnc\u00fc hasta \u00f6l\u00fcm\u00fc ortaya \u00e7\u0131kt\u0131 \u2192 Ertesi g\u00fcn <strong>%40 \u00e7\u00f6k\u00fc\u015f<\/strong><\/li>\n<li><strong>28 Temmuz 2025<\/strong>: FDA ambulatuvar hastalar i\u00e7in yeniden ba\u015flatmay\u0131 onaylad\u0131 \u2192 <strong>%23 toparlanma s\u0131\u00e7ramas\u0131<\/strong><\/li>\n<\/ul>\n<p>Desen a\u00e7\u0131k: olumsuz g\u00fcvenlik haberleri an\u0131nda ciddi d\u00fc\u015f\u00fc\u015flere neden olurken, olumlu d\u00fczenleyici geli\u015fmeler keskin toparlanmalar\u0131 tetikliyor. Bu volatilite SRPT ile zamanlamay\u0131 her \u015fey yap\u0131yor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu: Umuttan Krize<\/h2>\n<p>SRPT&#8217;nin \u015eubat&#8217;tan A\u011fustos 2025&#8217;e yolculu\u011fu bir t\u0131bbi gerilim roman\u0131 gibi:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: Yakla\u015f\u0131k $85 civar\u0131nda i\u015flem g\u00f6r\u00fcyordu (kriz \u00f6ncesi g\u00fcven)<\/li>\n<li><strong>Mart 2025<\/strong>: \u0130lk g\u00fcvenlik a\u00e7\u0131klamas\u0131ndan sonra $45&#8217;e d\u00fc\u015ft\u00fc<\/li>\n<li><strong>Haziran 2025<\/strong>: Geni\u015fletilmi\u015f FDA soru\u015fturmas\u0131yla $32&#8217;ye geriledi<\/li>\n<li><strong>Temmuz 2025<\/strong>: \u00dc\u00e7\u00fcnc\u00fc hasta \u00f6l\u00fcm\u00fc sonras\u0131 $19&#8217;a \u00e7ak\u0131ld\u0131<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: K\u0131smi FDA onay\u0131 ile $20.18&#8217;e toparland\u0131<\/li>\n<\/ul>\n<p>Bu, zirveden dip seviyeye <strong>%76&#8217;l\u0131k bir d\u00fc\u015f\u00fc\u015f<\/strong> anlam\u0131na geliyor\u2014her yat\u0131r\u0131mc\u0131n\u0131n sinirlerini s\u0131nayacak kadar. $19&#8217;dan gelen son s\u0131\u00e7rama biraz f\u0131rsat avc\u0131l\u0131\u011f\u0131na i\u015faret ediyor, ancak teknik zararlar ciddi kalmaya devam ediyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 (Y\u0131l Sonu)<\/strong>: $25-35 \u2192 <strong>TUT<\/strong> (Kas\u0131m kazan\u00e7 a\u00e7\u0131klamas\u0131n\u0131 bekleyin)<\/li>\n<li><strong>2026<\/strong>: $40-60 (d\u00fczenleyici \u00e7\u00f6z\u00fcm ve sat\u0131\u015f toparlanmas\u0131 varsay\u0131larak)<\/li>\n<li><strong>2028<\/strong>: $80-120 (gen terapisi platformu uzun vadede g\u00fcvenli olursa)<\/li>\n<li><strong>2030<\/strong>: $100-150+ (g\u00fcvenlik endi\u015feleri \u00e7\u00f6z\u00fcl\u00fcrse potansiyel blockbuster stat\u00fcs\u00fc)<\/li>\n<\/ul>\n<p>Analistlerin ortalama hedefi $45.65 olup <strong>%126 y\u00fckseli\u015f potansiyeli<\/strong> g\u00f6steriyor, ancak hedefler $7 ile $170 aras\u0131nda de\u011fi\u015fiyor, yani kimse tam olarak bilmiyor. Bu, biyoteknoloji spek\u00fclasyonunun en saf hali.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Yat\u0131r\u0131mc\u0131lar\u0131 Uykusuz B\u0131rakan Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici iptal<\/strong>: FDA ELEVIDYS onay\u0131n\u0131 tamamen geri \u00e7ekebilir<\/li>\n<li><strong>Dava tsunamisi<\/strong>: Birden fazla toplu dava milyarlarca dolara mal olabilir (<a href=\"https:\/\/www.rgrdlaw.com\/cases-sarepta-therapeutics-inc-class-action-lawsuit-srpt.html\">Robbins Geller<\/a>)<\/li>\n<li><strong>\u0130flas riski<\/strong>: $414M negatif nakit ak\u0131\u015f\u0131 sonsuza kadar devam edemez<\/li>\n<li><strong>\u0130tibar kayb\u0131<\/strong>: Gen terapisi platformuna olan g\u00fcven sars\u0131ld\u0131<\/li>\n<\/ul>\n<h3>Cesur Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>FDA k\u0131smi onay\u0131<\/strong>: Ambulatory hastalar tedaviye geri d\u00f6nd\u00fc (<a href=\"https:\/\/www.statnews.com\/2025\/07\/28\/sarepta-duchenne-elevidys-hold-ambulatory\/\">STAT News<\/a>)<\/li>\n<li><strong>Pazar liderli\u011fi<\/strong>: Hala Duchenne kas distrofisi tedavisinde lider<\/li>\n<li><strong>De\u011ferinin alt\u0131nda potansiyel<\/strong>: DCF analizine g\u00f6re %32 i\u00e7sel de\u011ferin alt\u0131nda<\/li>\n<li><strong>Short squeeze potansiyeli<\/strong>: Yo\u011fun k\u0131sa pozisyonlar h\u0131zl\u0131 toparlanmay\u0131 tetikleyebilir<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Kas\u0131m kazan\u00e7lar\u0131n\u0131 bekleyin<\/strong>: \u015eu anda \u00e7ok fazla belirsizlik var<\/li>\n<li><strong>Al\u0131m yapacaksan\u0131z k\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3&#8217;\u00fcnden fazlas\u0131n\u0131 ay\u0131rmay\u0131n<\/li>\n<li><strong>S\u0131k\u0131 stop-loss koyun<\/strong>: Bu hisse bir gecede %40 d\u00fc\u015febilir<\/li>\n<li><strong>Riski \u00e7e\u015fitlendirin<\/strong>: Stabil sa\u011fl\u0131k hisseleri ile dengeleyin<\/li>\n<\/ol>\n<p>Mizahi bir yorum: &#8220;SRPT ticareti, anestezisiz kalp ameliyat\u0131 yapmak gibidir\u2014hayatta kal\u0131rsan\u0131z heyecan verici, ama hasta masada \u00f6lebilir.&#8221;<\/p>\n<h2>\u2705 Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ticaret platformu se\u00e7in<\/td>\n<td>ABD biyoteknoloji hisseleri i\u00e7in NASDAQ eri\u015fimi sunmal\u0131<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Y\u00fcksek volatilite nedeniyle k\u00fc\u00e7\u00fck miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;SRPT&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Sadece limit emirleri\u2014bu volatilitede piyasa emirleri asla<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon oranlar\u0131n\u0131n %0.5&#8217;in alt\u0131nda oldu\u011fundan emin olun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Neden Volatil Biyoteknoloji Ticareti \u0130\u00e7in Uygun<\/h2>\n<p>SRPT gibi hisselerin ticareti, Pocket Option&#8217;\u0131n m\u00fckemmel sundu\u011fu esneklik gerektirir:<\/p>\n<ul>\n<li><strong>$5 minimum depozito<\/strong> \u2014 ger\u00e7ek para ile stratejileri test edin, kira paran\u0131z\u0131 riske atmay\u0131n<\/li>\n<li><strong>An\u0131nda do\u011frulama<\/strong> \u2014 herhangi bir kimlik y\u00fckleyin ve dakikalar i\u00e7inde ticarete ba\u015flay\u0131n, g\u00fcnler de\u011fil<\/li>\n<li><strong>Kripto dostu \u00e7ekimler<\/strong> \u2014 f\u0131rsatlar do\u011fdu\u011funda kazanc\u0131n\u0131z\u0131 h\u0131zl\u0131ca \u00e7ekin<\/li>\n<\/ul>\n<p>G\u00fcnde %40 hareket edebilen biyoteknoloji hisseleri i\u00e7in, geleneksel brokerlerin sunamad\u0131\u011f\u0131 platform \u00e7evikli\u011fi gerekir.<\/p>\n<h2>\ud83c\udf0d Sarepta 2025&#8217;te: Kriz ve F\u0131rsat<\/h2>\n<p>Sarepta Therapeutics, \u00fc\u00e7 FDA onayl\u0131 tedavi ile Duchenne kas distrofisi tedavi pazar\u0131nda lider konumda, ancak 2025 neredeyse \u00f6l\u00fcm deneyimi olarak hat\u0131rlanacak. \u015eirket, son aksiliklere ra\u011fmen hassas genetik t\u0131pta liderli\u011fini s\u00fcrd\u00fcr\u00fcyor, piyasa de\u011feri $1.97 milyar ve y\u0131ll\u0131k geliri $2.48 milyar (<a href=\"https:\/\/stockanalysis.com\/stocks\/srpt\/\">StockAnalysis<\/a>).<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: Temmuz 2025&#8217;te Sarepta, 2026&#8217;ya kadar $400M tasarruf etmek i\u00e7in 500 \u00e7al\u0131\u015fan\u0131n\u0131 (i\u015f g\u00fcc\u00fcn\u00fcn %36&#8217;s\u0131) i\u015ften \u00e7\u0131karaca\u011f\u0131n\u0131 duyurdu\u2014g\u00fcvenlik sorunlar\u0131n\u0131n ard\u0131ndan en b\u00fcy\u00fck biyoteknoloji yeniden yap\u0131lanmalar\u0131ndan biri (<a href=\"https:\/\/en.wikipedia.org\/wiki\/Sarepta_Therapeutics\">Wikipedia<\/a>).<\/p>\n"},"faq":[{"question":"Sarepta Therapeutics hisseleri nereden al\u0131n\u0131r?","answer":"Sarepta Therapeutics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6r\u00fcr. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden SRPT sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"SRPT hissesinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda FDA onay\u0131n\u0131n iptali, toplu davalar, y\u00fcksek negatif nakit ak\u0131\u015f\u0131 ve gen terapisi platformuna olan g\u00fcvenin sars\u0131lmas\u0131 yer al\u0131r."},{"question":"SRPT hissesinde yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Kas\u0131m 2025 kazan\u00e7 raporunu beklemek, k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flamak, s\u0131k\u0131 stop-loss kullanmak ve portf\u00f6y\u00fcn\u00fcz\u00fc \u00e7e\u015fitlendirmek \u00f6nemlidir."},{"question":"SRPT hissesinin fiyat tahmini nedir?","answer":"2025 sonunda $25-35 aras\u0131, 2026'da $40-60, 2028'de $80-120 ve 2030'da $100-150+ aral\u0131\u011f\u0131nda tahmin edilmektedir, ancak volatilite y\u00fcksek ve belirsizlik fazlad\u0131r."},{"question":"Pocket Option SRPT ticareti i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama ve kripto para \u00e7ekim kolayl\u0131\u011f\u0131 ile Pocket Option, y\u00fcksek volatiliteye sahip biyoteknoloji hisseleri i\u00e7in esnek ve h\u0131zl\u0131 bir platform sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Sarepta Therapeutics hisseleri nereden al\u0131n\u0131r?","answer":"Sarepta Therapeutics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6r\u00fcr. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden SRPT sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"SRPT hissesinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda FDA onay\u0131n\u0131n iptali, toplu davalar, y\u00fcksek negatif nakit ak\u0131\u015f\u0131 ve gen terapisi platformuna olan g\u00fcvenin sars\u0131lmas\u0131 yer al\u0131r."},{"question":"SRPT hissesinde yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Kas\u0131m 2025 kazan\u00e7 raporunu beklemek, k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flamak, s\u0131k\u0131 stop-loss kullanmak ve portf\u00f6y\u00fcn\u00fcz\u00fc \u00e7e\u015fitlendirmek \u00f6nemlidir."},{"question":"SRPT hissesinin fiyat tahmini nedir?","answer":"2025 sonunda $25-35 aras\u0131, 2026'da $40-60, 2028'de $80-120 ve 2030'da $100-150+ aral\u0131\u011f\u0131nda tahmin edilmektedir, ancak volatilite y\u00fcksek ve belirsizlik fazlad\u0131r."},{"question":"Pocket Option SRPT ticareti i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama ve kripto para \u00e7ekim kolayl\u0131\u011f\u0131 ile Pocket Option, y\u00fcksek volatiliteye sahip biyoteknoloji hisseleri i\u00e7in esnek ve h\u0131zl\u0131 bir platform sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T14:37:21+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T14:37:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/\"},\"wordCount\":20,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/\",\"name\":\"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-20T14:37:21+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T14:37:21+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T14:37:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/"},"wordCount":20,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/","name":"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-20T14:37:21+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Sarepta Therapeutics, Inc. (SRPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sarepta Therapeutics, Inc. (SRPT) Hisse Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":341329,"slug":"how-to-buy-sarepta-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Sarepta Therapeutics, Inc. (SRPT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Sarepta Therapeutics, Inc. (SRPT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":341323,"slug":"how-to-buy-sarepta-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Sarepta Therapeutics, Inc. (SRPT) - Investimento em a\u00e7\u00f5es da Sarepta Therapeutics, Inc. (SRPT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-sarepta-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=341324"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341324\/revisions"}],"predecessor-version":[{"id":341327,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341324\/revisions\/341327"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=341324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=341324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=341324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}